Overview
Ichthyosis follicularis-alopecia-photophobia syndrome (IFAP syndrome), also known as ichthyosis follicularis with atrichia and photophobia, is a rare genetic disorder characterized by a triad of distinctive features: ichthyosis follicularis (widespread spiny follicular hyperkeratosis affecting the skin), alopecia (absence or severe reduction of hair from birth), and photophobia (extreme sensitivity to light). The condition primarily affects the skin, hair, and eyes. The ichthyosis follicularis manifests as non-inflammatory keratotic projections arising from hair follicles distributed over most of the body, giving the skin a rough, thorn-like texture. The alopecia is typically universal or near-universal, affecting the scalp, eyebrows, eyelashes, and body hair. Photophobia can be severe and is often associated with corneal and other ocular abnormalities. Additional features may include short stature, intellectual disability, seizures, recurrent infections, and various other ectodermal abnormalities such as nail dystrophy and dental anomalies. Some patients may also develop psoriasiform dermatitis, angular cheilitis, and eczema. The condition is caused by mutations in the MBTPS2 gene located on the X chromosome, which encodes a membrane-bound transcription factor protease involved in cholesterol homeostasis and endoplasmic reticulum stress response. The disease predominantly affects males, while carrier females may show variable, often milder manifestations. There is currently no cure for IFAP syndrome. Treatment is symptomatic and supportive, focusing on management of skin symptoms with emollients and keratolytic agents, protection of the eyes from light exposure using tinted lenses or sunglasses, and addressing associated complications such as seizures or infections. A multidisciplinary approach involving dermatology, ophthalmology, neurology, and genetics is recommended for optimal patient care.
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Ichthyosis follicularis-alopecia-photophobia syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ichthyosis follicularis-alopecia-photophobia syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Ichthyosis follicularis-alopecia-photophobia syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ichthyosis follicularis-alopecia-photophobia syndrome.
Community
No community posts yet. Be the first to share your experience with Ichthyosis follicularis-alopecia-photophobia syndrome.
Start the conversation →Latest news about Ichthyosis follicularis-alopecia-photophobia syndrome
No recent news articles for Ichthyosis follicularis-alopecia-photophobia syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ichthyosis follicularis-alopecia-photophobia syndrome
What is Ichthyosis follicularis-alopecia-photophobia syndrome?
Ichthyosis follicularis-alopecia-photophobia syndrome (IFAP syndrome), also known as ichthyosis follicularis with atrichia and photophobia, is a rare genetic disorder characterized by a triad of distinctive features: ichthyosis follicularis (widespread spiny follicular hyperkeratosis affecting the skin), alopecia (absence or severe reduction of hair from birth), and photophobia (extreme sensitivity to light). The condition primarily affects the skin, hair, and eyes. The ichthyosis follicularis manifests as non-inflammatory keratotic projections arising from hair follicles distributed over most
How is Ichthyosis follicularis-alopecia-photophobia syndrome inherited?
Ichthyosis follicularis-alopecia-photophobia syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Ichthyosis follicularis-alopecia-photophobia syndrome typically begin?
Typical onset of Ichthyosis follicularis-alopecia-photophobia syndrome is neonatal. Age of onset can vary across affected individuals.